| Issue Date | Title | Author(s) |
| 1 | 2015 | A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2 | 2015 | The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 3 | Oct-2015 | Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
| 4 | 2015 | A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cells | Adan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf |
| 5 | Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
| 6 | 2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| 7 | 2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 8 | 2015 | Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cells | Adan Gökbulut, Aysun |
